News

  • 20 July 2018

    UNC Lineberger finds new target for kidney cancer

    University of North Carolina (UNC) Lineberger Comprehensive Cancer Center has discovered a new potential therapeutic target for clear cell renal cell carcinoma (RCC), the most common form of kidney cancer....

  • 20 July 2018

    Deals this week: Merck, Apotex, Dare Bioscience

    Merck has signed a co-development agreement with Xian-Janssen Pharmaceutical to launch its INVOKANA (canagliflozin) drug, which is indicated for the treatment of type 2 diabetes, in China.

  • 19 July 2018

    Novartis postpones drug price hike

    Swiss pharmaceutical conglomerate Novartis has announced it will pause scheduled drug price increases for the remainder of 2018, alongside reporting its positive second quarter (Q2) earnings and updating full year...

  • 19 July 2018

    Roivant launches new startup Sinovant Sciences in China

    Global healthcare company Roivant Sciences has launched a spin-off called Sinovant Sciences in Shanghai, China, to primarily develop innovative therapeutics through biomedical research and development (R&D).